Method of treating cancer with combinations of histone deacetylase inhibitors (HDAC1… Grant US-11890269-B2 United States of America 06 Feb 2024
Tolerogenic synthetic nanocarriers for allergy therapy Grant US-11779641-B2 United States of America 10 Oct 2023
Methods and compositions for attenuating anti-viral transfer vector immune responses Grant US-11633422-B2 United States of America 25 Apr 2023
Methods and compositions related to combined treatment with antiinflammatories and… Grant US-11426451-B2 United States of America 30 Aug 2022
Self-assembled drug-loading system and preparation method therefor Grant US-11331387-B2 United States of America 17 May 2022
Methods providing a therapeutic macromolecule and synthetic nanocarriers comprising… Grant US-11298342-B2 United States of America 12 Apr 2022
Compositions and methods for adhesion to surfaces Grant US-11247941-B2 United States of America 15 Feb 2022
Methods for providing polymeric synthetic nanocarriers for generating antigen-specific… Grant US-11235057-B2 United States of America 01 Feb 2022
Targeted nanocarriers for the administration of immunosuppressive agents Grant US-11214805-B2 United States of America 04 Jan 2022
TARGETED NANOCARRIERS FOR THE ADMINISTRATION OF IMMUNOSUPPRESSIVE AGENTS Grant EP-3094314-B1 European Patent Office 23 Jun 2021
Tolerogenic synthetic nanocarriers to reduce or prevent anaphylaxis in response to a non-al… Grant US-10668053-B2 United States of America 02 Jun 2020
Controlled release system including a gas or volatile encapsulated in a polymeric support… Grant US-10449156-B2 United States of America 22 Oct 2019
Tolerogenic synthetic nanocarriers for generating CD8+ regulatory T cells Grant US-10441651-B2 United States of America 15 Oct 2019
Methods related to administering immunosuppressants and therapeutic macromolecules at a… Grant US-10434088-B2 United States of America 08 Oct 2019
Tolerogenic synthetic nanocarriers for antigen-specific deletion of T effector cells Grant US-10420835-B2 United States of America 24 Sep 2019
Methods providing a therapeutic macromolecule and synthetic nanocarriers comprising… Grant US-10357482-B2 United States of America 23 Jul 2019
Methods of administering immunosuppressants having a specified pharmacodynamic effective… Grant US-10335395-B2 United States of America 02 Jul 2019
Methods and compositions for attenuating gene expression modulating anti-viral transfer… Grant US-10071114-B2 United States of America 11 Sep 2018
Methods and compositions for attenuating exon skipping anti-viral transfer vector immune… Grant US-10046064-B2 United States of America 14 Aug 2018
Method for providing polymeric synthetic nanocarriers for generating antigen-specific… Grant US-10039822-B2 United States of America 07 Aug 2018
Tolerogenic synthetic nanocarriers for generating CD8+ regulatory T cells Grant US-10004802-B2 United States of America 26 Jun 2018
Tolerogenic synthetic nanocarriers for inducing regulatory B cells Grant US-9993548-B2 United States of America 12 Jun 2018
Tolerogenic synthetic nanocarriers for antigen-specific deletion of T effector cells Grant US-9987354-B2 United States of America 05 Jun 2018
METHODS AND COMPOSITIONS RELATED TO SYNTHETIC NANOCARRIERS WITH RAPAMYCIN IN A STABLE… Application WO-2016073799-A1 World Intellectual Property Organisation (WIPO) 12 May 2016